These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7603161)
1. Should factor XII assays be included in thrombophilia screening? Winter M; Gallimore M; Jones DW Lancet; 1995 Jul; 346(8966):52. PubMed ID: 7603161 [No Abstract] [Full Text] [Related]
2. [Coagulation factor XII deficiency, a contribution to thrombophilia]. Klare M Z Gesamte Inn Med; 1984 Nov; 39(22):562-4. PubMed ID: 6528678 [TBL] [Abstract][Full Text] [Related]
3. [Determination of factor XII and plasma prekallikrein with chromozym PK]. Stürzebecher J; Klessen C; Markwardt F Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817 [No Abstract] [Full Text] [Related]
4. Why do we want to know how factor XII levels are modulated? Schmaier AH Thromb Res; 2010 Feb; 125(2):105-6. PubMed ID: 19850327 [No Abstract] [Full Text] [Related]
5. Hageman factor (factor XII) in health and diseases. Saito H Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1460-5. PubMed ID: 7342648 [No Abstract] [Full Text] [Related]
6. [Plasma factor XII (Hageman factor) in disease states (author's transl)]. Ichinose A; Maruyama I; Imaguma M; Sonoda T; Igata A Rinsho Ketsueki; 1981 Aug; 22(8):1232-6. PubMed ID: 7328776 [No Abstract] [Full Text] [Related]
7. [Platelet polyphosphates: new mediators linking thrombosis with inflammation]. Kerbiriou-Nabias D Med Sci (Paris); 2010 Apr; 26(4):343-6. PubMed ID: 20412734 [No Abstract] [Full Text] [Related]
8. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait. Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of factor XII analysis in blood coagulation tests]. Saito H Nihon Rinsho; 1989 Dec; 48 Suppl():843-5. PubMed ID: 2622016 [No Abstract] [Full Text] [Related]
10. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]. Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686 [TBL] [Abstract][Full Text] [Related]
11. Adult cystic fibrosis patients with and without infective exacerbations and their factor XII levels. Davidson SJ; Paramothayan S; Hodson ME Blood Coagul Fibrinolysis; 2009 Sep; 20(6):400-2. PubMed ID: 19525847 [TBL] [Abstract][Full Text] [Related]
14. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates. Kluft C; Svendsen L; Los P Adv Exp Med Biol; 1983; 156():201-4. PubMed ID: 6190367 [No Abstract] [Full Text] [Related]
15. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients. Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834 [TBL] [Abstract][Full Text] [Related]
18. Intrinsic pathway of coagulation and arterial thrombosis. Gailani D; Renné T Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770 [TBL] [Abstract][Full Text] [Related]
19. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis]. Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836 [TBL] [Abstract][Full Text] [Related]